Parents with children ... receive in a full vaccine series. In the beginning of February, Pfizer announced that the company submitted data from the two-dose vaccine for authorization at the ...

Moderna is seeking emergency use authorization from the US Food and Drug Administration for its Covid-19 vaccine for children 6 months through 5 years of age, the company said Thursday. “We ...

A Moderna executive hopes authorization ... The vaccine company Moderna on Thursday announced it submitted its request for the Food and Drug Administration to authorize its vaccine for children ...

Pfizer and BioNTech filed a request with the US Food and Drug Administration in the first week of February for an emergency use authorization of their vaccine in children 6 months to 5 years old.

Pfizer has already applied for emergency use authorization for its coronavirus vaccine for teens and children ages 12 to 15. The FDA is poised to authorize Pfizer’s coronavirus vaccine in that ...

Pfizer and its German partner, BioNTech, on Wednesday finished submitting an application for regulatory authorization of a coronavirus vaccine for children younger than 5. The development marked ...

Pfizer expects to request emergency use authorization for its COVID-19 vaccine to be given to children ages 2 to 11 in September as vaccine manufacturers work to get approval to administer doses ...

It would be the first COVID-19 vaccine available to young children. Pfizer asked the Food and Drug Administration on Tuesday for emergency use authorization for its COVID-19 vaccine for children ...

The FDA said in a statement that it is delaying a vaccine advisory-panel ... of our decision-making for potential authorization,” read the statement. Children in Pfizer’s clinical trials ...

By Sharon LaFraniere WASHINGTON — Moderna said on Wednesday that it would seek emergency authorization of its coronavirus vaccine for children younger than 6, after interim results from its ...

Vaccine maker Moderna requested emergency use authorization Thursday of its coronavirus vaccine for babies, toddlers and young children — a highly anticipated step toward making shots available ...

Clinical trial data showed that children ... authorization application for its vaccines in children 6 to 11 years old. The study enrolled 6,700 young children to determine the proper dosage of ...